Nuclear receptor ligands: Rational and effective therapy for chronic cholestatic liver disease?

Gastroenterology

Volumn 129, Issue 2, 2005, Pages 735-740

  Boyer, James L ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 [2 [2 CHLORO 4 [3 (2,6 DICHLOROPHENYL) 5 ISOPROPYL 4 ISOXAZOLYLMETHOXY] PHENYL]VINYL]BENZOIC ACID; 3 [2 [2 CHLORO 4 [3 (2,6 DICHLOROPHENYL) 5 ISOPROPYL 4 ISOXAZOLYLMETHOXY]PHENYL]VINYL]BENZOIC ACID; 6 ETHYLCHENODESOXYCHOLIC ACID; ALITRETINOIN; BILE ACID; CELL NUCLEUS RECEPTOR; CHOLIC ACID DERIVATIVE; CONSTITUTIVE ANDROSTANE RECEPTOR; HORMONE RECEPTOR STIMULATING AGENT; HYPERICUM PERFORATUM EXTRACT; LIGAND; LITHOCHOLIC ACID; OXYSTEROL; PHENOBARBITAL; PLANT EXTRACT; PREGNANE X RECEPTOR; RETINOIC ACID; RIFAMPICIN; UNCLASSIFIED DRUG; URSODEOXYCHOLIC ACID; VITAMIN D; XENOBIOTIC AGENT;

CHOLESTASIS; CHRONIC LIVER DISEASE; DRUG METABOLISM; GENE CONTROL; GENE EXPRESSION; GENE TARGETING; HUMAN; HYPERICUM PERFORATUM; LIGAND BINDING; LIVER CLEARANCE; LIVER MICROSOME METABOLISM; NEWBORN JAUNDICE; NONHUMAN; PRIORITY JOURNAL; PRURITUS; REVIEW;

EID: 23344432870     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gastro.2005.06.053     Document Type: Review

References (34)

1. A. Chawla, J.J. Repa, R.M. Evans, D.J. Mangelsdorf Nuclear receptors and lipid physiology opening the X-files Science 294 2001 1866 1870
2. T.M. Willson, S.A. Jones, J.T. Moore, S.A. Kliewer Chemical genomics functional analysis of orphan nuclear receptors in the regulation of bile acid metabolism Med Res Rev 21 2001 513 522
3. S.J. Karpen Nuclear receptor regulation of hepatic function J Hepatol 36 2002 832 850
4. B. Goodwin, J.T. Moore CAR detailing new models Trends Pharmacol Sci 25 2004 437 441
5. W. Huang, J. Zhang, D.D. Moore A traditional herbal medicine enhances bilirubin clearance by activating the nuclear receptor CAR J Clin Invest 113 2004 137 143
6. H.-U. Marshall, M. Wagner, G. Zollner, P. Fickert, U. Diczfalusy, J. Gumhold, D. Silbert, A. Fuchsbichler, L. Benthin, R. Grundström, U. Gustafsson, S. Sahlin, C. Einarsson, M. Trauner Complementary stimulation of hepatobiliary transport and detoxification systems by rifampicin and ursodeoxycholic acid in humans Gastroenterology 129 2005 476 485
7. J.J. Eloranta, G.A. Kullak-Ublick Coordinate transcriptional regulation of bile acid homeostasis and drug metabolism Arch Biochem Biophys 433 2005 397 412
8. J.Y.L. Chiang Bile acid regulation of hepatic physiology III. Bile acids and nuclear receptors Am J Physiol 284 2003 G349 G356
9. M. Trauner, M. Wagner, P. Fickert, G. Zollner Molecular regulation of hepatobiliary transport systems clinical implications for understanding and treating cholestasis J Clin Gastroenterol 39 4 Suppl 2 2005 S111 S124
10. G. Zollner, P. Fickert, D. Silbert, A. Fuchsbichler, H.-U. Marschall, K. Zatloukal, H. Denk, M. Trauner Adaptive changes in hepatobiliary transporter expression in primary biliary cirrhosis J Hepatol 38 2003 717 727
11. M.B.U.W.T.K.D.K.D.H.R.K. Verena Keitel Expression and localization of hepatobiliary transport proteins in progressive familial intrahepatic cholestasis Hepatology 41 2005 1160 1172
12. G.L. Guo, G. Lambert, M. Negishi, J.M. Ward, H.B. Brewer Jr, S.A. Kliewer, F.J. Gonzalez, C.J. Sinal Complementary roles of farnesoid X receptor, pregnane X receptor, and constitutive androstane receptor in protection against bile acid toxicity J Biol Chem 278 2003 45062 45071
13. C.A. Stedman, C. Liddle, S.A. Coulter, J. Sonoda, J.G. Alvarez, D.D. Moore, R.M. Evans, M. Downes Nuclear receptors constitutive androstane receptor and pregnane X receptor ameliorate cholestatic liver injury Proc Natl Acad Sci U S A 102 2005 2063 2068
14. P.L. Jansen, M. Muller, E. Sturm Genes and cholestasis Hepatology 34 2001 1067 1074
15. J.Y.L. Chiang Regulation of bile acid synthesis pathways, nuclear receptors, and mechanisms J Hepatol 40 2004 539 551
16. Y. Liu, J. Binz, M.J. Numerick, S. Dennis, G. Luo, B. Desai, K.I. MacKenzie, T.A. Mansfield, S.A. Kliewer, B. Goodwin, S.A. Jones Hepatoprotection by the farnesoid X receptor agonist GW4064 in rat models of intra- and extrahepatic cholestasis J Clin Invest 112 2003 1678 1687
17. S. Fiorucci, C. Clerici, E. Antonelli, S. Orlandi, B. Goodwin, B.M. Sadeghpour, G. Sabatino, G. Russo, D. Castellani, T.M. Willson, M. Pruzanski, R. Pellicciari, A. Morelli Protective effects of 6-ethyl chenodeoxycholic acid, a farnesoid x receptor ligand, in estrogen-induced cholestasis J Pharmacol Exp Ther 313 2005 604 612
18. C.J. Sinal, M. Tohkin, M. Miyata, J.M. Ward, G. Lambert, F.J. Gonzalez Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis Cell 102 2000 731 744
19. A. Moschetta, A.L. Bookout, D.J. Mangelsdorf Prevention of cholesterol gallstone disease by FXR agonists in a mouse model Nat Med 10 2004 1352 1358
20. S.P. Saini, J. Sonoda, L. Xu, D. Toma, H. Uppal, Y. Mu, S. Ren, D.D. Moore, R.M. Evans, W. Xie A novel constitutive androstane receptor-mediated and CYP3A-independent pathway of bile acid detoxification Mol Pharmacol 65 2004 292 300
21. M. Assem, E.G. Schuetz, M. Leggas, D. Sun, K. Yasuda, G. Reid, N. Zelcer, M. Adachi, S. Strom, R.M. Evans, D.D. Moore, P. Borst, J.D. Schuetz Interactions between hepatic Mrp4 and Sult2a as revealed by the constitutive androstane receptor and Mrp4 knockout mice J Biol Chem 279 2004 22250 22257
22. W. Huang, J. Zhang, D.D. Moore A traditional herbal medicine enhances bilirubin clearance by activating the nuclear receptor CAR J Clin Invest 113 2004 137 143
23. J.R. Bloomer, J.L. Boyer Phenobarbital effects in cholestatic liver disease Ann Intern Med 82 1975 310 317
24. J. Zhang, W. Huang, M. Qatanani, R.M. Evans, D.D. Moore The constitutive androstane receptor and pregnane X receptor function coordinately to prevent bile acid-induced hepatotoxicity J Biol Chem 279 2004 49517 49522
25. K. Dilger, A. Denk, M.H. Heeg, U. Beuers No relevant effect of ursodeoxycholic acid on cytochrome P450 3A metabolism in primary biliary cirrhosis Hepatology 41 2005 595 602
26. C.N. Ghent, S.G. Carruthers Treatment of pruritus in primary biliary cirrhosis with rifampin. Results of a double-blind, crossover, randomized trial Gastroenterology 94 1988 488 493
27. L. Bachs, M. Elena, A. Pares, C. Piera, J. Rodes Comparison of rifampicin with phenobarbitone for treatment of pruritus in biliary cirrhosis Lancet 1 1989 574 576
28. H. Wietholtz, H.U. Marschall, J. Sjovall, S. Matern Stimulation of bile acid 6 alpha-hydroxylation by rifampin J Hepatol 24 1996 713 718
29. E.L. Cancado, R.M. Leitao, F.J. Carrilho, A.A. Laudanna Unexpected clinical remission of cholestasis after rifampicin therapy in patients with normal or slightly increased levels of gamma-glutamyl transpeptidase Am J Gastroenterol 93 1998 1510 1517
30. G. Zollner, P. Fickert, A. Fuchsbichler, D. Silbert, M. Wagner, S. Arbeiter, F.J. Gonzalez, H.-U. Marschall, K. Zatloukal, H. Denk, M. Trauner Role of nuclear bile acid receptor, FXR, in adaptive ABC transporter regulation by cholic and ursodeoxycholic acid in mouse liver, kidney and intestine J Hepatol 39 2003 480 488
31. E.G. Schuetz, S. Strom, K. Yasuda, V. Lecureur, M. Assem, C. Brimer, J. Lamba, R.B. Kim, V. Ramachandran, B.J. Komoroski, R. Venkataramanan, H. Cai, C.J. Sinal, F.J. Gonzalez, J.D. Schuetz Disrupted bile acid homeostasis reveals an unexpected interaction among nuclear hormone receptors, transporters, and cytochrome P450 J Biol Chem 276 2001 39411 39418
32. Paumgarnter GABU. Mechanisms of action and therapeutic efficacy of ursodeoxycholic acid in cholestatic liver disease. Clin Liver Dis 204;8:67-81.
33. J. Lee, J.L. Boyer Molecular alterations in hepatocyte transport mechanisms in acquired cholestatic liver disorders Semin Liver Dis 20 2000 373 384
34. M. Trauner, J.L. Boyer Bile salt transporters molecular characterization, function and regulation Physiol Rev 83 2003 633 671